[
  {
    "ts": null,
    "headline": "AbbVie Inc. stock rises Friday, still underperforms market",
    "summary": "AbbVie Inc. stock rises Friday, still underperforms market",
    "url": "https://finnhub.io/api/news?id=428e30322d0f32f99dfdba25906334650e1904fed048ee500d8371f832da5bed",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735922040,
      "headline": "AbbVie Inc. stock rises Friday, still underperforms market",
      "id": 132322051,
      "image": "",
      "related": "ABBV",
      "source": "MarketWatch",
      "summary": "AbbVie Inc. stock rises Friday, still underperforms market",
      "url": "https://finnhub.io/api/news?id=428e30322d0f32f99dfdba25906334650e1904fed048ee500d8371f832da5bed"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie to Host Full-Year and Fourth-Quarter 2024 Earnings Conference Call",
    "summary": "AbbVie (NYSE: ABBV) will announce its full-year and fourth-quarter 2024 financial results on Friday, January 31, 2025, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time. It will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.",
    "url": "https://finnhub.io/api/news?id=3c2fd701de20ed3ec76bcb2d5c4134db8a55153a64e95170a2bf204cefea739b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735909200,
      "headline": "AbbVie to Host Full-Year and Fourth-Quarter 2024 Earnings Conference Call",
      "id": 132252791,
      "image": "https://media.zenfs.com/en/prnewswire.com/a5eaa0af5f515703fe951de405417559",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "AbbVie (NYSE: ABBV) will announce its full-year and fourth-quarter 2024 financial results on Friday, January 31, 2025, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time. It will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.",
      "url": "https://finnhub.io/api/news?id=3c2fd701de20ed3ec76bcb2d5c4134db8a55153a64e95170a2bf204cefea739b"
    }
  },
  {
    "ts": null,
    "headline": "The Zacks Analyst Blog Eli Lilly, J&J, AbbVie, AstraZeneca and Pfizer",
    "summary": "Eli Lilly, J&J, AbbVie, AstraZeneca and Pfizer are included in this Analyst Blog.",
    "url": "https://finnhub.io/api/news?id=19a8f5d3363fd6f907ef59b816f30cbc03162df4407ca23c13c9dd0cb1d9b032",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735890300,
      "headline": "The Zacks Analyst Blog Eli Lilly, J&J, AbbVie, AstraZeneca and Pfizer",
      "id": 132249155,
      "image": "https://media.zenfs.com/en/zacks.com/60c096e1e24bb285c41a58d325d8d707",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Eli Lilly, J&J, AbbVie, AstraZeneca and Pfizer are included in this Analyst Blog.",
      "url": "https://finnhub.io/api/news?id=19a8f5d3363fd6f907ef59b816f30cbc03162df4407ca23c13c9dd0cb1d9b032"
    }
  }
]